B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GLP2R

MOLECULAR TARGET

glucagon like peptide 2 receptor

UniProt: O95838NCBI Gene: 93401 compounds

GLP2R (glucagon like peptide 2 receptor) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GLP2R

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Glucagon-Like Peptide 21.393

About GLP2R as a Drug Target

GLP2R (glucagon like peptide 2 receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented GLP2R interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GLP2R inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.